Maravai LifeSciences Holdings, Inc. MRVI Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s accounts receivable?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported accounts receivable of $33.42M in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s accounts receivable changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s accounts receivable increased by 17.3% year-over-year, from $28.49M to $33.42M.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s accounts receivable?
- Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s accounts receivable has grown at a -28.0% compound annual growth rate (CAGR), from $388.81M to $104.41M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.